Document is current
Any future updates will be listed below
-
Authors
Machlin, Jordan H. https://orcid.org/0000-0002-8858-9248
Potocsky, Kate
Kruger, Robin E. https://orcid.org/0000-0002-2190-2455
Spence, Jason https://orcid.org/0000-0001-7869-3992
Padmanabhan, Vasantha https://orcid.org/0000-0002-8443-7212
Shikanov, Ariella https://orcid.org/0000-0003-0159-6419
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (5T32HD079342-10, GM145470, R01HD099402-01A1)
Chan Zuckerberg Initiative
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 3 September 2025
First Online: 26 September 2025
Declarations
:
: The IIAM procures tissue and organs from Organ Procurement Organizations (OPOs) for non-clinical research. OPOs comply with state Uniform Anatomical Gift Acts (UAGA) and are certified and regulated by the Centers for Medicare and Medicaid Services (CMS). These OPOs are members of the Organ Procurement and Transplantation Network (OPTN) and the United Network for Organ Sharing (UNOS) and operate under a set of standards established by the Association of Organ Procurement Organizations (AOPO) and UNOS. Informed, written consent from the deceased donor’s family was obtained for the tissue used in this publication. A biomaterial transfer agreement is in place between IIAM and the University of Michigan that allows the use of the tissue for pre-clinical research that does not involve the fertilization of gametes. The use of deceased donor ovarian tissue in this research is categorized as “not regulated,” per 45 CFR 46.102 and the “Common Rule,” and complies with the University of Michigan’s IRB requirements as such.
: The authors declare no competing interests.
